Patients could be hurt by efforts to curb meth abuse

February 2011
Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p40
Trade Publication
The article reports on the issues concerning the policy which requires prescriptions for over-the-counter (OTC) medications containing pseudoephedrine (PSE) for the treatment of common cold or flu in the U.S. It states that the policy was imposed to curb methamphetamine abuse. It highlights the study conducted by the Asthma and Allergy Foundation of America (AAFA) which revealed that 71 percent of patients with astha, cold and flu opposed the prescription laws for the medications.


Related Articles

  • States move to restrict OTC ephedrine.  // Drug Topics;10/10/94, Vol. 138 Issue 19, p8 

    Reports that the states of Missouri, Ohio and Florida have imposed restrictions on the sale of over the counter ephedrine products by reclassifying the drug.

  • Using a Risk-Based Approach for the Treatment of Cough and Colds.  // American Health & Drug Benefits;2008 Supplement, Vol. 1, p4 

    The article discusses the possible risks associated with numerous medications employed in treating respiratory infections, such as cough and colds, and to inform stakeholders of the recent policy changes made by the U.S. Food and Drug Administration (FDA) on the way such products are...

  • FDA OKs OTC Zyrtec.  // Drug Topics;12/10/2007, Vol. 151 Issue 23, p6 

    The article discusses the approval that McNeil Consumer Healthcare got from Food and Drug administration for their application of Zyrtec (cetirizine HCl) to be used without prescription. This drug is applicable for both adults and children. Zyrtec relieves symptoms caused by both perennial and...

  • New HIPAA standards coming for electronic claims and transmissions. Milenkovich, Ned // Drug Topics;Aug2011, Vol. 155 Issue 8, p56 

    The article focuses on the standards for electronic transactions of pharmacies under the Health Insurance Portability and Accountability Act (HIPAA) in the U.S. It states that pharmacies are required to update its National Council for Prescription Drug Program (NCPDP) 5.1 to NCPDP D.0 for...

  • Unofficial and untapped: China's over-the-counter drug market. Swanson, Mitzi // China Business Review;Mar/Apr94, Vol. 21 Issue 2, p34 

    Reports on China's policy for over-the-counter (OTC) drug market. Definition of OTC drugs; Increase in OTC purchases; Plans of foreign companies to invest in China; Government policy regarding foreign companies and joint ventures; Enforcement of state regulations on pharmaceutical production...

  • Popular drug ingredients banned.  // Nutrition Health Review: The Consumer's Medical Journal;Summer91, Issue 59, p12 

    Reports on the US Food and Drug Administration's prohibition of the inclusion of 223 nonprescription drug ingredients in products due to absence of proofs presented confirming their effectiveness. Products affected by ruling; Ingredients banned from use.

  • Rx-to-OTC shift: Not for these widely-used drugs. Chase, Sandra L. // RN;Jan95, Vol. 58 Issue 1, p67 

    Reports on the Food & Drug Administration's (FDA) denial of petitions for conversion of several prescription medications to over-the-counter (OTC) status. Disapproval of cimetidine and famotidine due to drug interactions; Topical minoxidil; Bronchodilators and asthma medication.

  • Government to tackle postcode prescribing.  // Pulse;4/7/2003, Vol. 63 Issue 14, p11 

    Reports that the British government plans to tackle postcode prescribing with guidelines on a range of treatments including those for cancer, coronary heart disease and obesity.

  • Ohio blames managed care for prescription delays.  // Drug Store News;9/22/97, Vol. 19 Issue 15, pCP1 

    Reports on the Ohio State Board of Pharmacy's issuance of new rules requiring pharmacies to transfer prescription information to other pharmacies at the request of the patient.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics